Definitive Healthcare Business Summary

Definitive Healthcare Corp. (DH) operates as a leading provider of healthcare commercial intelligence, primarily generating revenue through a high-margin, SaaS-based subscription model. The company’s platform, anchored by its proprietary Atlas Dataset, aggregates and analyzes billions of data points to provide a 360-degree view of the U.S. healthcare ecosystem, including provider affiliations, patient volumes, and referral patterns. Its primary business segments cater to the biopharmaceutical, medical device, and healthcare information technology sectors, helping clients optimize go-to-market strategies and clinical trial planning. In the competitive landscape, Definitive Healthcare contends with major players such as IQVIA, Innovaccer, and Verily; while IQVIA dominates in global scale and clinical data, Definitive Healthcare maintains a specialized market position by offering granular, actionable intelligence specifically tailored for commercial execution and market segmentation within the domestic healthcare landscape. The company was founded in 2011 by Jason Krantz, who currently serves as Executive Chairman and previously built the pharmaceutical intelligence firm Infinata. The leadership team is led by CEO Kevin Coop, appointed in June 2024, who brought over 30 years of experience from data-centric firms including DailyPay, Dun & Bradstreet, and Black Knight. Supporting the executive overhaul is CFO Casey Heller, a former IBM finance executive, and Benjamin Graboske, who joined in March 2025 as EVP of Technology and Engineering and Chief Data Officer, bringing a pedigree from ICE and Black Knight’s data analytics divisions. Definitive Healthcare is backed by prominent institutional investors, with Advent International holding a significant majority stake alongside Spectrum Equity, Goldman Sachs, and BlackRock, reflecting a strong institutional confidence in the company’s long-term data-as-a-service strategy.